Petros Pharmaceuticals

Entity > Corporation > US > New York City New York > Petros Pharmaceuticals

About Petros Pharmaceuticals

Petros Pharmaceuticals, Inc. is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring and commercializing innovative therapeutics for men's health issues, including erectile dysfunction, Peyronie's disease, hormone health and substance use disorders.

Petros Pharmaceuticals, Inc. Launches Two Self-Selection Studies For Erectile Dysfunction Drug Stendra® (Avanafil): Results from these studies will be part of a broader data package the company plans to submit to the U.S. Food and Drug Administration (FDA) to potentially obtain over-the-counterdrug status for STENDRA® (avanafil).

Petros Pharmaceuticals Is Expanding Its Program For A Novel, Non-Invasive Treatment For Peyronie's Disease: In an effort to expand its portfolio to other underserved segments, Petros Pharmaceuticals recently entered into a definitive global exclusive license agreement for a novel and patented topical formulation candidate for the treatment of Peyronie's disease (PD), which is currently in early clinical testing. If approved, this would be the first and only clinically proven topical, non-invasive treatment for acute PD, a breakthrough achievement in men's health.

Petros Pharmaceuticals' Foundation: Petros Pharmaceuticals, formerly known as Metuchen Pharma, was founded in 2020 and is headquartered in the United States.

Petros Pharmaceuticals' Vision: Petros Pharmaceuticals' vision is to provide optimised men's health solutions that address the full spectrum of conditions that are specific to men, whether they focus on the male anatomy or pose an increased risk to men.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Petros Pharmaceuticals

Company Attribute Value
Address StreetAddress: 1185 Avenue of the Americas Fl 3, AddressLocality: New York City, AddressRegion: New York, PostalCode: 10036, AddressCountry: United States
Founding Date 2020
Name Petros Pharmaceuticals
Number Of Employees 24
Revenue $6,201,000 USD
Ticker Symbol NASDAQ: PTPI
Url petrospharma
Google google

Petros Pharmaceuticals


New York City, US
24 Jun 2024

New York City, US
24 Jun 2024

Petros Pharmaceuticals

Page: 1 Desktop | Laptop Devices
Petros Pharmaceuticals
Expanding Consumer Access To Medication Through Over-The- Counter (OTC) Drug Development Programs. Petros Pharmaceuticals is committed to the goal of becoming a ... › quote › PTPI
Petros Pharmaceuticals, Inc. (PTPI) Stock Price, News, ...
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally.
Petros Pharmaceuticals (@PetrosPharma) · X › ... › United States
Petros Pharmaceuticals Inc. Stock Quote (U.S. - PTPI
Petros Pharmaceuticals, Inc. engages in men's health therapeutics. It is involved in sales, marketing, regulatory and medical affairs, finance, trade relations, ...
Petros Pharmaceuticals
At Petros, we are bringing new approaches to the most challenging conditions in men's health. We seek to understand the various health ... › view › petros-pharmaceut...
Petros Pharmaceuticals Executive Discusses Wider ...
Mar 28, 2024 — In an interview with Pharm Exec Associate Editor Don Tracy, Fady Boctor, President, Chief Commercial Officer, Petros Pharmaceuticals talks about ... › quote › PTPI › news
Petros Pharmaceuticals, Inc. (PTPI) Latest Stock News & ...
/ Petros Pharmaceuticals, Inc. (Nasdaq:PTPI), a pioneer in expanding consumer access to medication through over the counter (OTC) pathways, announces today that ...
Related Searches
Related Searches
Petros pharmaceuticals stock
Petros pharmaceuticals stock price
Petros pharmaceuticals products
Knowledge Panel
Knowledge Panel

Petros Pharma (Pharmaceutical company)

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices.,Prescription%20Medications%20and%20Medical%20Devices.
  • Stock price : PTPI (NASDAQ) $0.41 -0.01 (-2.81%)Jun 21, 4:00 PM EDT - Disclaimer
  • Headquarters : United States
  • Founded : 2020

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 193781